CA
BSX icon

Continental Advisors’s Boston Scientific BSX Stock Holding History

Continental Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-57,100
Closed -$1.42M – 98
2017
Q4 		$1.42M Sell
57,100
-10,000
-15% -$276K 0.31% 79
2017
Q3 		$1.96M Buy
+67,100
New +$1.85M 0.45% 66
2013
Q4 		– Sell
-30,000
Closed -$352K – 142
2013
Q3 		$352K Buy
+30,000
New +$325K 0.09% 127

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Continental Advisors's BSX Position: Q3 2022 in Review

Continental Advisors sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 9,512 shares — an estimated $355K sold.

Continental Advisors first reported a position in BSX in Q2 2013 and held it in 37 quarters. The position peaked at $3.32M in Q3 2016. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • Continental Advisors reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
  • Continental Advisors sold 9,512 Boston Scientific shares in Q3 2022, an estimated $355K.
  • Continental Advisors first reported a position in Boston Scientific in Q2 2013 and held it in 37 quarters.
  • Continental Advisors's Boston Scientific position peaked at $3.32M in Q3 2016.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Continental Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.